This innovative program will provide funding, career guidance, education and skill acquisition for aspiring clinical scientists working at the Medical Center.
Clinical scholars who excel will be viewed as potential faculty recruits. Appropriate discussions will be initiated with such individuals to ascertain whether their career goals can be served by a faculty appointment at Cedars-Sinai, including considerations of start-up support for an independent research career.
| ISSUES IN CLINICAL AND TRANSLATIONAL RESEARCH |
BIOSTATISTICS |
| Design of epidemiologic studies |
Biostatistics - Confounding, bias, study design |
| Testing a hypothsis; asking a good question |
Biostatistics - (finish study design) - Descriptive statistics for continuous data |
| Design of clinical trials |
Biostatistics - Descriptive statistics for binary and survival data |
| Measures and how they influence data analysis: Categorical measures |
Biostatistics - Elementary probability theory & distributions - Normal distribution |
| Measures and how they influence data analysis: Continuous measures |
Biostatistics - Central limit theorem & confidence intervals |
| Randomization, sample size and power |
Biostatistics - Hypothesis testing & equivalence testing |
| Data collection, recording, storage and management |
Biostatistics - Power, sample size, incomplete (missing) data |
| Questionnaire design and psychometrics |
Biostatistics - Correlation, bivariate and multiple regression - an introduction |
| Data and Safety Monitoring |
Biostatistics - Comparing means - t tests and analysis of variance |
| Bioinformatics and information system for clinical research |
Biostatistics - Binary outcomes - comparing proportions - chi square tests |
| Bioinformatics and information system for clinical research |
Biostatistics - Binary outcomes - introduction to logistic regression and quantal response |
| Good Clinical Practices (GCP) |
Biostatistics - Statistical reporting in scientific papers - wrap up & review |
| Clinical Trial Management |
|
| FDA and ICH Regulations for Drugs and Devices |
|